Trial · NCT01200758
Adverse events390
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 390
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 47 | 210 | |
| other | Nausea | Gastrointestinal disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 65 | 197 | |
| other | Constipation | Gastrointestinal disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 55 | 210 | |
| other | Constipation | Gastrointestinal disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 50 | 197 | |
| other | Diarrhoea | Gastrointestinal disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 35 | 210 | |
| other | Diarrhoea | Gastrointestinal disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 34 | 197 | |
| other | Vomiting | Gastrointestinal disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 27 | 210 | |
| other | Vomiting | Gastrointestinal disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 29 | 197 | |
| other | Abdominal pain | Gastrointestinal disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 25 | 210 | |
| other | Abdominal pain | Gastrointestinal disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 29 | 197 | |
| other | Dyspepsia | Gastrointestinal disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 14 | 210 | |
| other | Dyspepsia | Gastrointestinal disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 16 | 197 | |
| other | Injection site erythema | General disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 0 | 210 | |
| other | Injection site erythema | General disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 27 | 197 | |
| other | Fatigue | General disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 38 | 210 | |
| other | Fatigue | General disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 42 | 197 | |
| other | Asthenia | General disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 27 | 210 | |
| other | Asthenia | General disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 35 | 197 | |
| other | Pyrexia | General disorders | Stage I and II: Rituximab IV + Chemotherapy (CHOP/CVP) | 29 | 210 | |
| other | Pyrexia | General disorders | Stage I and II: Rituximab SC + Chemotherapy (CHOP/CVP) | 29 | 197 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01200758/events